Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria An Official American Thoracic Society Workshop Report

the Assembly on Pulmonary Infections and Tuberculosis

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

6 Citas (Scopus)

Resumen

Pneumonia imposes a significant clinical burden on people with immunocompromising conditions. Millions of individuals live with compromised immunity because of cytotoxic cancer treatments, biological therapies, organ transplants, inherited and acquired immunodeficiencies, and other immune disorders. Despite broad awareness among clinicians that these patients are at increased risk for developing infectious pneumonia, immunocompromised people are often excluded from pneumonia clinical guidelines and treatment trials. The absence of a widely accepted definition for immunocompromised host pneumonia is a significant knowledge gap that hampers consistent clinical care and research for infectious pneumonia in these vulnerable populations. To address this gap, the American Thoracic Society convened a workshop whose participants had expertise in pulmonary disease, infectious diseases, immunology, genetics, and laboratory medicine, with the goal of defining the entity of immunocompromised host pneumonia and its diagnostic criteria.

Idioma originalInglés estadounidense
Páginas (desde-hasta)341-353
-13
PublicaciónAnnals of the American Thoracic Society
Volumen20
N.º3
DOI
EstadoIndizado - mar. 2023

Nota bibliográfica

Publisher Copyright:
Copyright © 2023 by the American Thoracic Society.

Huella

Profundice en los temas de investigación de 'Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria An Official American Thoracic Society Workshop Report'. En conjunto forman una huella única.

Citar esto